Margaret Beaudoin's most recent trade in Verve Therapeutics Inc was a trade of 10,799 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 17, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Verve Therapeutics Inc | Margaret Beaudoin | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 10,799 | 10,799 | - | - | Stock Option (right to buy) | |
| Verve Therapeutics Inc | Margaret Beaudoin | Vice President, Finance | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 17 Jun 2021 | 1,000 | 1,000 | - | 19 | 19,000 | Common Stock |